All News

The standardization of value-based models is crucial as they become widely-adopted.

The gut microbiome may play a key role impact the severity of multiple sclerosis symptoms.

The sixth annual National Association of Specialty Pharmacy meeting features numerous educational sessions and networking opportunities for specialty pharmacy stakeholders.

Patients with cancer experienced a reduction in fatigue after 3 weeks of knowingly taking a placebo.

An artificial liver infected with hepatitis B demonstrates physiological reaction of a real human liver.

Some patients may be unwilling to undergo traditional screening for cervical cancer.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Risk adjustment must be effective to achieve insurance market reform and expand coverage to new enrollees.

GDC-0084 is a small molecule inhibitor of phosphatidylinositol 3-kinase with potential antineoplastic activity.

The latest DrugStats database list shows the medications with increasing numbers of prescriptions.

There have been multiple concerns levied about PBM tactics that have led plan sponsors and pharmacy stakeholders to push back.

With Apple eyeing up the EHR space, the rational movement to get patients data through their iPhones is just the next place to start.

Identifying the right ingredients for change can help patients reduce their disease risk, improve health and empower them to adapt positive behaviors.

Top articles of the week from The American Journal of Pharmacy Benefits.

We talk to pharmacists with fascinating side hustles.

There are many mistakes, pitfalls, and unknowns that pharmacists routinely fail to consider before transitioning to another job.

Kempharma introduces newly approved pain management drug and warns of risk for addiction.

Kempharma introduces newly approved pain management drug and warns of risk for addiction.

Silly things happen in the Pharmacy

Specialty drugs are a large driver of health care spending.

Patients who exercise during chemotherapy may have lower levels of fatigue years after cancer treatments.

Cabozantinib (Cabometyx) treatment resulted in tumor shrinkage among patients with refractory thyroid cancer.

A look at the top stories in the world of pharmacy from last week.

Top news of the week from Specialty Pharmacy Times.

Experimental therapy could improve lifespan for patients with amyotrophic lateral sclerosis.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Medicaid was a leading payer for inpatient hospital stays among multiple age groups over a 15-year period.

Pharmacy benefit managers serve as a middleman between payers and pharmacies.